[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Seo et al., 2019 - Google Patents

Phenotypes of atopic dermatitis identified by cluster analysis in early childhood

Seo et al., 2019

Document ID
16619160823253365895
Author
Seo E
Yoon J
Jung S
Lee J
Lee B
Yu J
Publication year
Publication venue
The Journal of dermatology

External Links

Snippet

Atopic dermatitis is a chronic, relapsing, inflammatory skin disease that usually appears in early childhood and develops into a heterogeneous disease during childhood. The clinical course and treatment for atopic dermatitis can differ according to its phenotype and/or …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases

Similar Documents

Publication Publication Date Title
Seo et al. Phenotypes of atopic dermatitis identified by cluster analysis in early childhood
Marinho et al. Rhinoconjunctivitis in 5‐year‐old children: a population‐based birth cohort study
Siroux et al. The asthma‐rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults
Nyan et al. Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities
Husemoen et al. Association of obesity and insulin resistance with asthma and aeroallergen sensitization
Palmer et al. Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age
Wickman et al. Quantitative analysis of IgE antibodies to food and inhalant allergens in 4‐year‐old children reflects their likelihood of allergic disease
Harrop et al. Eczema, atopy and allergen exposure in adults: a population‐based study
Boralevi et al. Epicutaneous aeroallergen sensitization in atopic dermatitis infants–determining the role of epidermal barrier impairment
Yang et al. Association between allergic diseases, allergic sensitization and attention-deficit/hyperactivity disorder in children: A large-scale, population-based study
Tajiri et al. Prevalence and clinical relevance of allergic rhinitis in patients with classic asthma and cough variant asthma
Linneberg et al. Temporal trends of aeroallergen sensitization over twenty‐five years
Joseph-Bowen et al. Relationship of asthma, atopy, and bronchial responsiveness to serum eosinophil cationic proteins in early childhood
Kilpeläinen et al. Childhood farm environment and asthma and sensitization in young adulthood
Pekkarinen et al. A disparity in the association of asthma, rhinitis, and eczema with allergen‐specific IgE between Finnish and Russian Karelia
Bertelsen et al. Rhinitis in children: co‐morbidities and phenotypes
Bakkeheim et al. Altered oxidative state in schoolchildren with asthma and allergic rhinitis
Amelink et al. Non‐atopic males with adult onset asthma are at risk of persistent airflow limitation
Heinrich et al. Age‐dependent differences in the prevalence of allergic rhinitis and atopic sensitization between an eastern and a western German city
Julge et al. Development of allergy and IgE antibodies during the first five years of life in Estonian children
Sinagra et al. Unnecessary milk elimination diets in children with atopic dermatitis
Gürkan et al. Recurrent aphthous stomatitis in childhood and adolescence: a single‐center experience
Caillaud et al. Exercise‐induced bronchospasm related to different phenotypes of rhinitis without asthma in primary schoolchildren: the French Six Cities Study
Choi et al. Bronchial responsiveness to methacholine and adenosine 5′‐monophosphate in young children with asthma: their relationship with blood eosinophils and serum eosinophil cationic protein
Engebretsen et al. Xerosis is associated with asthma in men independent of atopic dermatitis and filaggrin gene mutations